| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |